Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia

References

• Konopleva M, Andreeff M. Targeting the leukemia microenvironment. Curr Drug Targets. 2007;8(6):685–701.
   PubMed Web of Science ®Google Scholar
• Shi J, Fu H, Jia Z, et al. High expression of CPT1A predicts adverse outcomes: a potential therapeutic target for acute myeloid leukemia. EBioMedicine. 2016;14:55–64.
   PubMed Web of Science ®Google Scholar
• Shah A, Andersson TM, Rachet B, et al. Survival and cure of acute myeloid leukaemia in England, 1971–2006: a population-based study. Br J Haematol. 2013;162(4):509–516.
   PubMed Web of Science ®Google Scholar
• Acheampong DO, Adokoh CK, Asante DB, et al. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomed Pharmacother. 2018;97:225–232.
   PubMed Web of Science ®Google Scholar
• Gittleman HR, Ostrom QT, Rouse CD, et al. Trends in central nervous system tumor incidence relative to other common cancers in adults, adolescents, and children in the United States, 2000 to 2010. Cancer. 2015;121(1):102–112.
   PubMed Web of Science ®Google Scholar
• Showel MM, Levis M. Advances in treating acute myeloid leukemia. F1000Prime Rep. 2014;6:96.
   PubMedGoogle Scholar
• Khan GN, Orchard K, Guinn BA. Antigenic targets for the immunotherapy of acute myeloid leukaemia. J Clin Med. 2019;8(2):134.
   Web of Science ®Google Scholar
• Estey E, Dohner H. Acute myeloid leukaemia. Lancet. 2006;368(9550):1894–1907.
   PubMed Web of Science ®Google Scholar
• Ryan JF, Hovde R, Glanville J, et al. Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets. Proc Natl Acad Sci U S A. 2016;113(9):E1286–E1295.
   PubMed Web of Science ®Google Scholar
• Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003;3(6):453–458.
   PubMed Web of Science ®Google Scholar
• Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39(1):1–10.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhang E, Long J, et al. Immune infiltration in renal cell carcinoma. Cancer Sci. 2019;110(5):1564–1572.
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457.
   PubMed Web of Science ®Google Scholar
• Chen B, Khodadoust MS, Liu CL, et al. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Zhang S, Chang YY, Gong YW, et al. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells. J Cell Biochem. 2019;120(4):6347–6360.
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Tan Q, et al. DAVID Bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(Web Server issue):W169–W175.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–D368.
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
   PubMed Web of Science ®Google Scholar
• Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929–1935.
   PubMed Web of Science ®Google Scholar
• Shen Y, Liu J, Zhang L, et al. Identification of potential biomarkers and survival analysis for head and neck squamous cell carcinoma using Bioinformatics strategy: a study based on TCGA and GEO datasets. Biomed Res Int. 2019;2019:7376034.
   PubMed Web of Science ®Google Scholar
• Cao J, Yang X, Li J, et al. Screening and identifying immune-related cells and genes in the tumor microenvironment of bladder urothelial carcinoma: based on TCGA database and bioinformatics. Front Oncol. 2020;9:1533.
   Web of Science ®Google Scholar
• Jin Y, Jin W, Zheng Z, et al. GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer. Biochem Biophys Res Commun. 2017;492(3):323–330.
   PubMed Web of Science ®Google Scholar
• Miwa T, Kanda M, Umeda S, et al. Homeobox c10 influences on the malignant phenotype of gastric cancer cell lines and its elevated expression positively correlates with recurrence and poor survival. Ann Surg Oncol. 2019;26(5):1535–1543.
   PubMed Web of Science ®Google Scholar
• Feng X, Li T, Liu Z, et al. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome. Mol Biosyst. 2015;11(11):2946–2954.
   PubMedGoogle Scholar
• Li F, Zhao S, Guo T, et al. The nutritional cytokine leptin promotes NSCLC by activating the PI3 K/AKT and MAPK/ERK pathways in NSCLC cells in a paracrine manner. Biomed Res Int. 2019;2019:2585743.
   PubMed Web of Science ®Google Scholar
• Misiano P, Scott BB, Scheideler MA, et al. PTH2 receptor-mediated inhibitory effect of parathyroid hormone and TIP39 on cell proliferation. Eur J Pharmacol. 2003;468(3):159–166.
   PubMed Web of Science ®Google Scholar
• Huang X, Wang Y, Nan X, et al. The role of the orphan G protein-coupled receptor 37 (GPR37) in multiple myeloma cells. Leuk Res. 2014;38(2):225–235.
   PubMed Web of Science ®Google Scholar
• Liu F, Zhu C, Huang X, et al. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival. Pathol Res Pract. 2014;210(12):885–892.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang L. [Up-regulation of GPR37 promotes the proliferation of human glioma U251 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018;34(4):341–345.
   PubMedGoogle Scholar
• Zerfaoui M, Errami Y, Naura AS, et al. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation. J Immunol. 2010;185(3):1894–1902.
   PubMed Web of Science ®Google Scholar
• Tepper S, Jeschke J, Bottcher K, et al. PARP activation promotes nuclear AID accumulation in lymphoma cells. Oncotarget. 2016;7(11):13197–13208.
   PubMedGoogle Scholar
• Patel V, Liaw B, Oh W. The role of ketoconazole in current prostate cancer care. Nat Rev Urol. 2018;15(10):643–651.
   PubMed Web of Science ®Google Scholar
• Esther J, Maughan BL, Anderson N, et al. Management of nonmetastatic castration-resistant prostate cancer: recent advances and future direction. Curr Treat Options Oncol. 2019;20(2):14.
   PubMed Web of Science ®Google Scholar
• Wybraniec MT, Wrobel W, Wilkosz K, et al. Pharmacological cardioversion with antazoline in atrial fibrillation: the results of the CANT study. J Am Heart Assoc. 2018;7(20):e010153.
   PubMed Web of Science ®Google Scholar
• Binkowski BJ, Makowski M, Kubinski P, et al. Effect of antazoline on electrophysiological properties of Atrial muscle and conduction system of the heart. Cardiovasc Drugs Ther. 2018;32(2):169–173.
   PubMed Web of Science ®Google Scholar
• Piotrowski R, Giebultowicz J, Baran J, et al. Antazoline-insights into drug-induced electrocardiographic and hemodynamic effects: results of the ELEPHANT II substudy. Ann Noninvasive Electrocardiol. 2017;22(5):e12441.
   PubMed Web of Science ®Google Scholar